PATENT CLAIM ANALYSIS

Application Number: 16304927
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-09
Patent Classification: ["544", "373000"]

Abstract:
Disclosed is a partly crystalline form of nintedanib ethanesulphonate and its preparation process.

Claim (Index 2):
A partially crystalline form of nintedanib ethanesulphonate according to  claim 1 , wherein IR spectrum shows absorption peaks at 3440, 1710, 1627, 1385, 1288 and 1225\u00b11.5 cm \u22121 , 2\u03b8 peaks at 6.8, 7.8 and 17.9 in the XRPD diffractogram at the CuK\u03b1 wavelength, and a DSC curve shows an exothermic peak at 143\u00b0 C. and an endothermic peak at 167\u00b0 C.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15453892', '16083886', '12601942', '15558050', '15474620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7244664648298429
- 35 USC 102 Novelty (BERT): 0.4435310067180059
- Combined Prediction Score: 0.6963729190186592
- Mean Citation Score: 68.58592800000001
- Max Citation Score: 78.56506
- Similarity Product: 59.45282976496816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test